Pangenomic Health Inc.
NARA
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.56% | -71.97% | -48.60% | 51.46% | -159.56% |
| Total Depreciation and Amortization | -95.65% | -95.65% | -95.65% | -34.78% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.89% | 204.17% | 121.45% | 15.76% | 1,741.60% |
| Change in Net Operating Assets | 51.47% | 13.10% | 321.38% | -31.36% | -67.82% |
| Cash from Operations | -164.83% | -359.48% | 91.55% | 113.31% | 84.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 298.94% | -- | -100.00% | -100.00% | -86.57% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,858.82% | -- | -- | -100.00% | -88.89% |
| Cash from Financing | 256.50% | -- | -99.52% | -100.00% | -87.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.92% | -93.10% | -- | 21.51% | 14.75% |